Skip to main content
Premium Trial:

Request an Annual Quote

NCI s Core Genotyping Facility to Use Inforsense KDE for Genetic Data Analysis

NEW YORK, Aug. 30 (GenomeWeb News) - The National Cancer Institute's core genotyping facility has selected InforSense's KDE as its high-throughput genetics data-analysis platform, the company said today.


Under the five-year agreement, scientists at the core facility in Gaithersburg, Md., will use InforSense KDE to develop applications for their own research and to publish analysis methods via a web portal.


"After an extensive review of the available commercial and open source options, we recognized that InforSense KDE is able to provide the functionality, flexibility, and scalability we need to support our research, and to develop caBIG (Cancer Biomedical Informatics Grid) compatible applications," said Meredith Yeager, scientific director of the genotyping facility, in a statement.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.